Prefrontal dopamine D1 receptors and working memory in schizotypal personality disorder: a PET study with [11C]NNC112

被引:20
|
作者
Thompson, Judy L. [1 ,5 ]
Rosell, Daniel R. [2 ,3 ]
Slifstein, Mark [1 ]
Girgis, Ragy R. [1 ]
Xu, Xiaoyan [1 ]
Ehrlich, Yosefa [2 ,3 ]
Kegeles, Lawrence S. [1 ,4 ]
Hazlett, Erin A. [2 ,3 ]
Abi-Dargham, Anissa [1 ,4 ]
Siever, Larry J. [2 ,3 ]
机构
[1] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA
[2] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA
[3] James J Peters Vet Affairs Med Ctr, Bronx, NY 10468 USA
[4] Columbia Univ Coll Phys & Surg, Dept Radiol, New York, NY 10032 USA
[5] Rutgers State Univ, Sch Hlth Related Profess, Scotch Plains, NJ 07076 USA
关键词
Schizotypal personality disorder; Schizophrenia; PET; Dopamine; Prefrontal cortex; Working memory; IN-VIVO BINDING; NEUROPSYCHOLOGICAL PERFORMANCE; SCHIZOPHRENIA SPECTRUM; NAIVE PATIENTS; D-1; RECEPTORS; TASK; SPECIFICITY; SELECTIVITY; TOMOGRAPHY; IMPAIRMENT;
D O I
10.1007/s00213-014-3566-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Schizotypal personality disorder (SPD) is associated with working memory (WM) impairments that are similar to those observed in schizophrenia. Imaging studies have suggested that schizophrenia is associated with alterations in dopamine D1 receptor availability in the prefrontal cortex (PFC) that may be related to the WM impairments that characterize this disorder. The aim of this study was to characterize prefrontal D1 receptor availability and its relation to WM performance in SPD. We used positron emission tomography (PET) and the radiotracer [C-11]NNC112 with 18 unmedicated SPD and 21 healthy control participants; as an index of D1 receptor availability, binding potential (BP) measures (BPF, BPND, and BPP) were calculated for prefrontal and striatal subregions. To assess WM, SPD participants completed the 2-back and Paced Auditory Serial Addition Test (PASAT). There were no significant group differences in PFC BP. BPF and BPP in the medial PFC were significantly negatively related to PASAT performance (r (s) = -0.551, p = .022 and r (s) = -0.488, p = .047, respectively), but BP was not related to 2-back performance. In contrast to what has been found in schizophrenia, SPD was not associated with significant alterations in prefrontal D1 receptor availability. Similar to previous schizophrenia findings, however, higher prefrontal D1 receptor availability was associated with poorer WM performance (as measured by the PASAT) in SPD. These findings suggest that schizophrenia and SPD may share a common pathophysiological feature related to prefrontal dopamine functioning that contributes to WM dysfunction, but that in SPD, alterations in D1 may occur only in a subset of individuals and/or to an extent that is minor relative to what occurs in schizophrenia.
引用
收藏
页码:4231 / 4240
页数:10
相关论文
共 50 条
  • [41] Striatal dopamine D2 receptors in medication-naive patients with major depressive disorder as assessed with [11C]raclopride PET
    Jussi Hirvonen
    Hasse Karlsson
    Jaana Kajander
    Juha Markkula
    Helena Rasi-Hakala
    Kjell Någren
    Jouko K. Salminen
    Jarmo Hietala
    Psychopharmacology, 2008, 197 : 581 - 590
  • [42] Nicotine Normalizes Increased Prefrontal Cortical Dopamine D1 Receptor Binding and Decreased Working Memory Performance Produced by Repeated Pretreatment with MK-801: A PET Study in Conscious Monkeys
    Hideo Tsukada
    Katsumasa Miyasato
    Shingo Nishiyama
    Dai Fukumoto
    Takeharu Kakiuchi
    Edward F Domino
    Neuropsychopharmacology, 2005, 30 : 2144 - 2153
  • [43] The Dopamine D2 Receptors in High-Affinity State and D3 Receptors in Schizophrenia: A Clinical [11C]-(+)-PHNO PET Study
    Graff-Guerrero, Ariel
    Mizrahi, Romina
    Agid, Ofer
    Marcon, Heidi
    Barsoum, Penny
    Rusjan, Pablo
    Wilson, Alan A.
    Zipursky, Robert
    Kapur, Shitij
    NEUROPSYCHOPHARMACOLOGY, 2009, 34 (04) : 1078 - 1086
  • [44] Nicotine normalizes increased prefrontal cortical dopamine D1 receptor binding and decreased working memory performance produced by repeated pretreatment with MK-801: A PET study in conscious monkeys
    Tsukada, H
    Miyasato, K
    Nishiyama, S
    Fukumoto, D
    Kakiuchi, T
    Domino, EF
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 (12) : 2144 - 2153
  • [45] Dopamine D2 Receptors Availability in the Dorsal Caudate and Learning in Patients with Schizophrenia: A Prospective PET [11C]-Raclopride Study
    Rajji, Tarek
    Mulsant, Benoit
    Nakajima, Shinichiro
    Caravaggio, Fernando
    Suzuki, Takefumi
    Uchida, Hiroyuki
    Gerretsen, Philip
    Mar, Wanna
    Pollock, Bruce
    Mamo, David
    Graff, Ariel
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S368 - S368
  • [46] Dopamine D2/3 receptor availability in cocaine use disorder individuals with obesity as measured by [11C]PHNO PET
    Matuskey, David
    Angarita, Gustavo A.
    Worhunsky, Patrick
    Koohsari, Sheida
    Gravel, Paul
    Pittman, Brian
    Gaiser, Edward C.
    Gallezot, Jean-Dominque
    Nabulsi, Nabeel
    Huang, Yiyun
    Carson, Richard E.
    Potenza, Marc N.
    Malison, Robert T.
    DRUG AND ALCOHOL DEPENDENCE, 2021, 220
  • [47] The dopamine D1 receptor agonist (S)-[11C]N-methyl-NNC 01-0259 is not sensitive to changes in dopamine concentrationa positron emission tomography examination in the monkey brain
    Finnema, S. J.
    Bang-Andersen, B.
    Jorgensen, M.
    Christoffersen, C. T.
    Gulyas, B.
    Wikstrom, H. V.
    Farde, L.
    Halldin, C.
    SYNAPSE, 2013, 67 (09) : 586 - 595
  • [48] Chronic NMDA antagonism impairs working memory, decreases extracellular dopamine, and increases D1 receptor binding in prefrontal cortex of conscious monkeys
    Tsukada, H
    Nishiyama, S
    Fukumoto, D
    Sato, K
    Kakiuchi, T
    Domino, EF
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 (10) : 1861 - 1869
  • [49] Occupancy of Dopamine D2 and D3 Receptors by a Novel D3 Partial Agonist BP1.4979:A [11C]-(+)-PHNO PET Study in Humans
    Le Foll, Bernard
    Di Ciano, Patricia
    Mansouri, Esmaeil
    Wilson, Alan A.
    Houle, Sylvain
    Boileau, Isabelle
    Leveille, A.
    Capet, M.
    Duvauchelle, Thierry
    Schwartz, Jean-Charles
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S453 - S454
  • [50] The effects of d-amphetamine on extrastriatal dopamine D2/D3 receptors: a randomized, double-blind, placebo-controlled PET study with [11C]FLB 457 in healthy subjects
    Aalto, Sargo
    Hirvonen, Jussi
    Kaasinen, Valtteri
    Hagelberg, Nora
    Kajander, Jaana
    Nagren, Kjell
    Seppala, Timo
    Rinne, Juha O.
    Scheinin, Harry
    Hietala, Jarmo
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (03) : 475 - 483